about
Cop, a caspase recruitment domain-containing protein and inhibitor of caspase-1 activation processingToll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.Interleukin-33 in asthma: how big of a role does it play?Anti-D (WinRho SD) treatment of children with chronic autoimmune thrombocytopenic purpura stimulates transient cytokine/chemokine production.Chronic hyperbaric exposure activates proinflammatory mediators in humans.The meteorology of cytokine storms, and the clinical usefulness of this knowledgePost-stroke infection: a role for IL-1ra?Dedifferentiated chondrocytes cultured in alginate beads: restoration of the differentiated phenotype and of the metabolic responses to interleukin-1beta.IL-1 inhibitors: novel agents in the treatment of rheumatoid arthritis.Association of the IL1RN gene VNTR polymorphism with human male infertility.The endogenous Th17 response in NO2-promoted allergic airway disease is dispensable for airway hyperresponsiveness and distinct from Th17 adoptive transfer.The multifaceted effects of polysaccharides isolated from Dendrobium huoshanense on immune functions with the induction of interleukin-1 receptor antagonist (IL-1ra) in monocytesExtracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR.Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.Therapeutic potential of targeting IL-1 and IL-18 in inflammation.Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosisDirect adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects.Cytokines in idiopathic inflammatory myopathies.IL-1ra Secreted by ATP-Induced P2Y2 Negatively Regulates MUC5AC Overproduction via PLCβ3 during Airway Inflammation.Immunomodulation using genetically engineered bacteria for type III-mediated delivery of heterologous antigens and cytokines: potential application in vaccine and therapeutical developments.Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.Genetic Associations of Interleukin-related Genes with Graves' Ophthalmopathy: a Systematic Review and Meta-analysisThe protective mechanism of QGC in feline esophageal epithelial cells by interleukin-1β treatment.The natural history of the anterior cruciate ligament-deficient knee. Changes in synovial fluid cytokine and keratan sulfate concentrations.Cytokine and Growth Factor Concentrations in Canine Autologous Conditioned Serum.Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1β and CCL2/MCP-1 in dengue fever and parvovirosis.The role of cytokines in hemolytic transfusion reactions.Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat.Regulation of interleukin-1alpha expression by integrins and epidermal growth factor receptor in keratinocytes from a mouse model of inflammatory skin disease.Comparison of innate and Th1-type host immune responses in Oesophagostomum dentatum and Trichuris suis infections in pigs.Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.Extracellular regulation of interleukin (IL)-1beta through lung epithelial cells and defective IL-1 type II receptor expression.Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.Dexamethasone suppresses release of soluble TNF receptors by human monocytes concurrently with TNF-alpha suppression.Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.Nitric oxide regulates interleukin 1 bioactivity released from murine macrophages.Release of cytokines and proteases from human peripheral blood mononuclear and polymorphonuclear cells following phagocytosis and LPS stimulation.Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell death.scAAVIL-1ra dosing trial in a large animal model and validation of long-term expression with repeat administration for osteoarthritis therapy.Ovarian interleukin-1 receptor antagonist in rats: gene expression, cellular localization, cyclic variation, and hormonal regulation of a potential determinant of interleukin-1 action.
P2860
Q28204263-C493AFDD-3E52-4E15-8BFF-F1F53EDB5330Q30308835-D1CF5D1C-FDFC-4233-947E-8C906B15BFC1Q30428491-BC1189DF-1E11-41C9-9EC4-CD0E07BC77DDQ33341449-99051EE9-46EA-4253-8C24-9E3FEACA79DEQ33425268-2949196B-D441-482B-99CC-C642DF5A8786Q33867213-196D0B5E-D10F-4495-97F6-3EF01744A45CQ33897235-71A3F10A-2823-438F-9DE2-4729F3C693B4Q34066868-4B12C0E6-C20E-40C3-B4C4-E7D6587A5D2DQ34074678-B37CFE97-4A6C-45EA-846B-7A9DBAD94C05Q34517357-19704B7D-9E49-4879-896B-728A32724E4FQ34999285-B6567A06-B156-4D5D-8294-6228F341ECA0Q35140248-5E92C701-9465-4616-8DF7-DA8DF73B0AFDQ35606790-8A39EC60-A939-4E8C-9E46-9A261C04AFA4Q35788358-3B7F0DCE-8F14-4053-A8D1-71E72D4598A9Q35790840-873A7B55-8C74-4E21-8F34-828B039339ACQ36367874-621E93A0-2E87-4FD5-86ED-510BFD7C1AB2Q36477567-5536550C-C37D-4EB2-8186-4C58E07F3E9CQ36504371-68E56EE7-6724-437E-9F89-B492D358C342Q36681235-6D6D34D6-3FD7-4E7D-A88A-6549C455AD03Q37602699-42FD1193-88AB-44FF-9DBA-60EC5A098CECQ38006975-40D8D0FE-B4AF-4735-9DE8-E4E4796F3C34Q38636465-230335FC-7B4F-4EEF-ABE3-FD86B1074CA3Q39067284-6F7B831D-A138-492E-8B09-9BA35E1C354FQ39452182-A4290365-2614-44ED-BAAD-8F5736B4DD7EQ39644655-AA7AFD98-A296-40B4-8EDB-17F58540E054Q40297063-17E1DCBE-B51F-40CE-ADD3-E4699298A8C3Q40505282-310D9E96-EC18-460B-9C35-D18A9A8CCB23Q40608792-2424C897-0E42-4846-AC20-443B312C2654Q40661757-2BE7DB3D-BFE6-4CD5-AD19-918CF7262603Q40894151-C49E038C-D251-4794-9446-95D88AB229CAQ40919170-46B157DF-D613-493A-BBE4-1F210AF3B13BQ40957042-8AF749E0-19BA-44F2-8660-A8865E581F32Q40969344-9619E047-5ABB-4332-BBF9-96160FDF0258Q41095708-3DE07517-6329-487D-9A47-26F9CF526C85Q41105196-92912811-9984-48A7-BDD4-32586985A1B6Q41168225-9E291F30-40C1-41BA-96EF-89698C1C39CCQ41178327-8D062063-C400-44ED-8C74-ABC60E8FF491Q41404410-768D709A-27B1-4449-B945-7736D1FFEEB3Q41493963-E0F95875-F9E4-49B8-8472-200F645148B0Q42473657-BB32FDDA-0E0E-4547-9A52-3D82DC90258D
P2860
description
article
@en
im Jahr 1993 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в 1993
@uk
ലേഖനം
@ml
name
Interleukin-1 Receptor Antagonist
@en
Interleukin-1 Receptor Antagonist
@nl
type
label
Interleukin-1 Receptor Antagonist
@en
Interleukin-1 Receptor Antagonist
@nl
prefLabel
Interleukin-1 Receptor Antagonist
@en
Interleukin-1 Receptor Antagonist
@nl
P1476
Interleukin-1 Receptor Antagonist
@en
P2093
William P. Arend
P304
P356
10.1016/S0065-2776(08)60535-0
P577
1993-01-01T00:00:00Z